Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Baker

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Clinical Psychiatry|December 1, 1992
Emergence of obsessive compulsive symptoms during treatment with clozapineR W Baker, K N Chengappa, J W Baird, et al.
International Clinical Psychopharmacology|July 21, 1998
Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatmentJ Thompson, K N Chengappa, C B Good, et al.
Schizophrenia Research|March 28, 1998
Inter-rater reliability of the neurological examination in schizophreniaR D Sanders, S D Forman, J N Pierri, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptionsK N Chengappa, S Sheth, J S Brar, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Increased cortisol: cortisone ratio in acute pulmonary tuberculosisR W Baker, B R Walker, R J Shaw, et al.
The Journal of Clinical Psychiatry|December 1, 1996
Predictive value of eosinophilia for neutropenia during clozapine treatmentD Ames, W C Wirshing, R W Baker, et al.
Archives of General Psychiatry|November 1, 2001
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparisonJ M Kane, S R Marder, N R Schooler, et al.
Clinical Pharmacology and Therapeutics|May 6, 2017
Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening DiseasesJ S Prescott, P A Andrews, R W Baker, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Clinical Psychiatry|December 1, 1992
Emergence of obsessive compulsive symptoms during treatment with clozapineR W Baker, K N Chengappa, J W Baird, et al.
International Clinical Psychopharmacology|July 21, 1998
Hepatitis, hyperglycemia, pleural effusion, eosinophilia, hematuria and proteinuria occurring early in clozapine treatmentJ Thompson, K N Chengappa, C B Good, et al.
Schizophrenia Research|March 28, 1998
Inter-rater reliability of the neurological examination in schizophreniaR D Sanders, S D Forman, J N Pierri, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptionsK N Chengappa, S Sheth, J S Brar, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2000
Increased cortisol: cortisone ratio in acute pulmonary tuberculosisR W Baker, B R Walker, R J Shaw, et al.
The Journal of Clinical Psychiatry|December 1, 1996
Predictive value of eosinophilia for neutropenia during clozapine treatmentD Ames, W C Wirshing, R W Baker, et al.
Archives of General Psychiatry|November 1, 2001
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparisonJ M Kane, S R Marder, N R Schooler, et al.
Clinical Pharmacology and Therapeutics|May 6, 2017
Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening DiseasesJ S Prescott, P A Andrews, R W Baker, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Pageof 8